DIANA I BRIXNER portrait
  • Executive Director of Pharmacotherapy Outcomes Research Center, Pharmacotherapy
  • Adjunct Professor, Pediatrics
  • Adjunct Professor, Population Health Sciences
  • Professor, Pharmacotherapy

Presentations

  • When Specialty Pharmacy Meets Personalized Medicine. AMCP 2013 Nexus, San Antonio, TX. October 18, 2013. , , 2013.
  • AMCP Foundation Symposium. HTA Outside the US. AMCP 2013 Nexus, San Antonio, TX. October 15, 2013. , , 2013.
  • Brixner DI. Health System Innovation and Research (HSIR) Program. [Presentation] Personalized Health Care Research in Utah: Opportunities, Resources, Collaborations. University of Utah, Salt Lake City, UT. , , 2013.
  • Singhal M, Brixner DI. Application of Real World Data in Alzheimers Disease. [Presentation] Alzheimer’s Association Research Roundtable in Washington, DC. , , 2013.
  • The Realistic Role of CER for Enhanced Decision-Making. Academy of Managed Care Pharmacy 25th Annual Meeting and Expo. San Diego, CA. , , 2013.
  • Brixner, DI. How Personalized Medicine is Changing the Paradigm for Establishing Value Using Real World Data. Academy of Managed Care Pharmacy 25th Annual Meeting and Expo. San Diego, CA. , , 2013.
  • Ghate S, Brixner D. Predictors of Monitoring of Metabolic Parameters in Adolescents on Antipsychotics. 165th APA Annual Meeting, Philadelphia, PA. , , 2012.
  • Adherence: The Key to Success for Gout Treatment. AMCP 24th Annual Meeting and Expo, San Francisco, CA. , , 2012.
  • Biskupiak J, Ghate S, Brixner, DI. Impact of Generic Warfarin Switching on Outcomes in Afib Patients and the Cost of Bleeding. Renal Outcomes in Afib Patients, Predicitors of Adherence in Afib Patients, Afib presentation to CARMA. University of Utah School of Medicine, Salt Lake City, Utah. , , 2012.
  • Use of Real World Data in Decision Making for Global Reimbursement. Novo Nordisk, Zurich, Switzerland. , , 2011.
  • Brixner DI. The Value of ISPOR to its Membership: Global & Local Perspectives. ISPOR South Africa 1st Annual Congress, Pretoria, South Africa. Aug. 18, 2008. , , 2011.
  • Health Economics Modeling. Multiple Sclerosis Market Access Workshop. Advisory Board Member. London, UK. , , 2011.
  • Application of Real World Databases in the U.S. AGENS Meeting (Working Group on the Use of Secondary Data) University of Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria. , , 2011.
  • Brixner, DI. Drug Information Used in the Managed Care Pharmacy P&T Decision Making Process; Current practice and Insights. AMCP and ISPOR 16th Annual International Meeting, Baltimore, MD. May 24, 2011. , , 2011.
  • Brixner DI, McAdam-Marx C, Hane CA, Biskupiak J, Deniz B, McGarry L. IN3: Costs Associated with HCV and Related Complications in the US from a Managed Care Payer’s Perspective. ISPOR 16th Annual International Meeting, Baltimore, MD. May 23-27, 2011. , , 2011.
  • Brixner DI, Albright F, Bollu V, Kuo KL, Raimundo K, Barney R, Stenehjem D. Integrating Data Source To Conduct Comprehensive Oncology Based Outcomes Research. Novartis Pharmaceuticals Corporation, ISPOR 16th Annual International Meeting, Baltimore, MD. May 23-27, 2011. , , 2011.
  • Brixner DI, McAdam-Marx C, Ye X, Bouchard J, Aagren M, Conner C. Bootstrapping Used to Provide Robust Mean and Variance Estimates for Comparing Patients Treated with Liraglutide to a Large Comparison Cohort. ISPOR 16th Annual International Meeting, Baltimore, MD. May 23-27, 2011. , , 2011.
  • Brixner DI, Sweet B. Formulary Management Knowledge Clinic. Synopsis: A Discussion on the Methods used for Health Technology Assessment (HTA) in Other Countries with a Review of the AMCP Format for Formulary Submission, Version 3.0 and its use in the United States, Abu Dhabi, UAE. March 4, 2011. , , 2011.
  • Brixner DI. Use of Health Economics Outcomes Research Evidence Toward Market Access of Health Technology. 1st Annual Health Economic Middle East Forum, Abu Dhabi, UAE. March 4, 2011. , , 2011.
  • Brixner DI. Healthcare and Economics. Oman Reimbursement Systems Workshop Global Advisory Board, Oman, UAE. February 28, 2011. , , 2011.
  • Brixner DI. “Pharmacotherapy Outcomes Research: Application in Pediatrics”, Intermountain Primary Children’s Medical Center Grand Rounds, January, 2011. , , 2011.
  • Brixner DI. Oderda G, Healthcare and Economics – Educating Researchers and Health-Care Policy Makers Regarding the Value of Providing Medicines. Asian Health Economics Training Workshop, Jakarta, Indonesia. Sept. 2010. , , 2010.
  • Brixner DI, Biskupiak J, Holtorf AP. Current and Future use of Health Economic and Outcomes Research Data in Decision Making, European Society of Medical Decision Making Workshop, Tyrol, Austria. May 31, 2010. , , 2010.
  • Brixner DI. Healthcare and Economics, Educating Researchers and Health-Care Policy Makers Regarding the Value of Providing Medicines. 2nd Global Health Care Summit, Dubai, UAE. May 4, 2010. , , 2010.
  • Brixner DI. U.S. Primary Care Practice Electronic Medical Record Database: GE Centricity. [Short Course] ISPOR 15th Annual International Meeting, Atlanta, GA. May, 2010. , , 2010.
  • Brixner DI, Oderda G. Healthcare and Economics, Educating Researchers and Health-Care Policy Makers Regarding the Value of Providing Medicines. Asian Health Economics Training Workshop, Jakarta, Indonesia. Jan. 14, 2010. , , 2010.
  • Brixner DI, McAdam-Marx C, Aagren M, Bouchard J, Yu J. Average Daily Dose of Analog Basal Insulin in Patients with Type 2 Diabetes: A Matched Case Control Analysis. IDF World Diabetes Congress, Montreal, Canada. Oct. 2009. , , 2009.
  • Brixner DI, Health Economics Modeling, Multiple Sclerosis Market Access Workshop, Advisory Board Member, London, UK. Sept 18, 2009. , , 2009.
  • 18 Month A1C and Weight Outcomes of Exenatide Therapy in Patients with Type-2 Diabetes in a Real-World Study. ISPOR 14th Annual International Meeting. Orlando FL. May 2009. , , 2009.
  • Brixner DI. Applications In Using Large Databases. [short course] ISPOR 14th Annual International Meeting, Orlando, Florida. May, 2009. , , 2009.
  • Brixner DI, McAdam-Marx C, Ye X, Misurski D, Wintle M, Fabunmi R. 18 Month A1C and Weight Outcomes of Exenatide Therapy in Patients with Type-2 Diabetes in a Real-World Study. ISPOR 14th Annual International Meeting, Orlando, Florida. May 2009. , , 2009.
  • Brixner DI. Applications In Using Large Databases. [short course] ISPOR 14th Annual International Meeting, Orlando Florida. May 2009. , , 2009.
  • Brixner DI. Invited Speaker at Global Health Economics Ad Board for Liraglutide, Copenhagen, DK. April 28-30, 2009. , , 2009.
  • Global Health Economics Ad Board for Liraglutide, Copenhagen, DK. April 28-30, 2009. , , 2009.
  • Guidelines for Research Using "Real World Data" Enhancing the Rigor and Utility of Medication Use Research A Consensus Development Conference. Rockville, MD Co-sponsored by AACP, PPRA, ISPOR, and USP. January 2009. , , 2009.
  • Brixner DI. Guidelines for Research Using “Real World Data”. Enhancing the Rigor and Utility of Medication Use Research A Consensus Development Conference. Rockville, MD. January 2009 Co-sponsored by AACP, PPRA, ISPOR, and USP. , , 2009.
  • Brixner DI. Bayer HealthCare: Global Health Economics and Outcomes Research Network Conference, Berlin, Germany. Dec. 10, 2008. , , 2008.
  • Brixner DI, Pharmacoeconomics in Value Based Decision Making Training Course for Bayer Healthcare Executives. Berlin, Germany. December 2008. , , 2008.
  • Brixner DI. The Use of Real World Data to Assess Compliance and Economics in Hypertension. Workshop. ISPOR 11th Annual European Congress, Athens, Greece. November 2008. , , 2008.
  • Brixner DI, Pharmacoeconomics in Value Based Decision Making Training Course for Bayer Healthcare Executives. Seoul, Korea. September 2008. , , 2008.
  • The Value of ISPOR to its Membership: Global and Local Perspectives. ISPOR South Africa 1st Annual Congress, Pretoria, South Africa. August 18, 2008. , , 2008.
  • Brixner DI, Pharmacoeconomics Basic and Advanced Short Courses First Annual South African ISPOR Chapter Meeting, Johannesburg, South Africa. August 2008. , , 2008.
  • Brixner DI, Pharmacoeconomics in Value Based Decision Making Training Course for Bayer Healthcare Executives. Guatemala. June 2008,. , , 2008.
  • Brixner DI. Oderda G. Health Economics and Outcomes Research, Latin America LA/LT Training Meeting, Guatemala, Mexico. May 20, 2008. , , 2008.
  • Brixner DI. Applications In Using Large Databases. [short course] ISPOR 13th Annual International Meeting, Toronto, Canada. May, 2008. , , 2008.
  • Brixner DI, Oderda G, Lieberman M. Comparison of EMR Data to US National Data. International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual European Congress, Dublin, Ireland. October, 2007. , , 2007.
  • Brixner DI. Real World Data in Healthcare Decision Making. European Science Foundation Conference on the Global Health Economy, Kiel, Germany. May 2007. , , 2007.
  • Brixner DI. Utilizing Large Databases in Outcomes Research [short course] ISPOR 12th Annual International Meeting. Arlington, VA. May 2007. , , 2007.
  • Brixner DI. The Prevalence and Burden of Migraine and Its Impact on Managed Care. Academy of Managed Care Pharmacy 19th Annual Meeting and Showcase, San Diego, CA. , , 2007.
  • Brixner DI, Holtorf AP, LaFleur J, Servatius D, Jeffries B, McBeth C. Statin Treatment of Diabetic Patients in Utah Medicaid. Utah Health Services Research Conference: Utah Health Services Research Meets Public Health Informatics, Salt Lake City, Utah. , , 2007.
  • Brixner DI. Pharmacoeconomics of COPD Management. American Society of Hospital Pharmacists Mid-year Meeting, Anaheim, California. 2006. , , 2006.
  • Brixner DI. Assessment of Cardiometabolic Risk in a Primary Care Electronic Medical Database. Academy of Managed Care Pharmacy Meeting, Seattle, Washington. 2006. , , 2006.
  • Brixner DI. Developing and Implementing Pharmacy Policy for Insomnia Therapies within Managed Care Plans. Academy of Managed Care Pharmacy Meeting, Seattle, Washington. 2006. , , 2006.
  • Brixner DI (presenter), Joish VN, McAdam-Marx C, Arondekar B, Hoblyuk R. Evaluation of Persistency and Outcomes in Patients on SU Combination Therapy with TZDs or Metformin. 2nd Annual Health Services Research Conference. , , 2006.
  • Brixner DI. Electronic Medical Records in Outcomes Research: The New Frontier. Jefferson Medical College; Philadelphia, PA. , , 2005.
  • Brixner DI, Corey-Lisle P, Oberg B, Tuomari V, Biskupiak JE. Complexity of Depression Treatments: Healthcare Utilization and Costs. APA Annual Meeting Toronto, Canada. , , 2005.
  • Brixner DI. Update on Department of Pharmacotherapy at the University of Utah. Utah Pharmacists Association Annual Meeting, St. George, Utah. , , 2005.
  • Brixner DI. Managing Your Osteoporosis Formulary to Maximize Bone Strength and Minimize Fracture. AMCP Annual Meeting; Denver, CO. , , 2005.
  • Brixner DI. Improving Outcomes in the Treatment of Lower Respiratory Tract Infections AMCP Framework on Quality Drug Therapy. AMCP Annual Meeting; Denver, CO. , , 2005.
  • Brixner DI. Assessment of the Prevalence and Costs of Osteoporosis Treatment Options in a Real World Setting. AMCP Symposium; Nashville, TN. , , 2005.
  • Brixner DI. The Case Against Excessive Cost Sharing for Biologics. AMCP Symposium, Nashville, TN. , , 2005.
  • Brixner DI, Jorgenson J. Relationship Between Health Systems and Colleges of Pharmacy - AACP-Sponsored Program at the ASHP Midyear Clinical Meeting. , , 2004.
  • Brixner DI. Managing the Continuum of Treatment: Modeling the Economic Impact of Treating Diabetes, Symposium in conjunction with the Academy of Managed Care Pharmacy. , , 2004.
  • Brixner DI. Managing the Continuum of Treatment: Modeling the Economic Impact of Treating Diabetes. , , 2004.
  • Brixner DI. The Management of COPD in Managed Care Systems, Pre-Meeting Symposium to the Academy of Managed Care Pharmacy. , , 2003.
  • Brixner DI. The Economics of Insomnia, Pre-Meeting Symposium to the Academy of Managed Care Pharmacy. , , 2003.
  • Brixner DI. Patient Management in Irritable Bowel Syndrome, American Society of Health System Pharmacists Midyear Meeting. ISPOR 8th Annual International Meeting. Arlington, VA. , , 2003.
  • Brixner DI. Evidenced Based Treatment Approaches to Irritable Bowel Syndrome, Pre-Meeting Symposium to the Academy of Managed Care Pharmacy. , , 2003.
  • Brixner DI. Utilization of the AMCP Format in Medicaid, Medicaid & Medicare, the Changing Landscape. , , 2003.
  • Brixner DI, Oderda G, Gunning K, LaFleur J, Stockdale W, Tyler L, Parke D, Orlando P. Reviews of Utah Medicaid High Utilizers to Control Drug Costs, Medicaid Summit. 2003. , , 2003.
  • Brixner DI. Migraine Matters: Relieving the Burden in Managed Care, Symposium in conjunction with the Academy of Managed Care Pharmacy. , , 2001.
  • Brixner DI. Monoclonal Antibodies in the Changing Health Care Environment. International Congress of Pharmaceutical Biotechnology, Ghent, Belgium. 1995. , , 1995.
  • Brixner DI. Sustainability of Off-patent Drug Policies in the Quest for Value. [Workshop Presentation] ISPOR 16th Annual European Congress. Dublin, Ireland. November 6, 2013. , , 2013.
  • Brixner DI. Health Care Transformation Scientific Advisory Board and Symposium. [Presentation] “Driving Health Care Transformation.” Park City, UT. , , 2013.
  • Data Consortiums: Answering Tomorrow’s Questions Today. AMCP 2013 Nexus, San Antonio, TX. October 17, 2013. , , 2013.
  • Using Large Health Care Databases for Research. AMCP 2013 Nexus, San Antonio, TX. October 16, 2013. , , 2013.
  • Brixner DI. Will Generic Use Policy Stand up to Resilience? [Workshop Presentation] 16th European Health Forum Gastein, Bad Hofgastein, Austria. , , 2013.
  • Real world healthcare costs at community level: generalizability to larger populations. , , 2013.
  • Brixner DI. Value Assessment of Technology: (CRAM) The Pharmacotherapy Outcomes Research Center, College of Pharmacy. University of Utah, Salt Lake City, UT. , , 2013.
  • Brixner DI. Value Assessment of Technology: (CRAM) Clinical Research and Methods. [Presentation] The Pharmacotherapy Outcomes Research Center, College of Pharmacy. University of Utah, Salt Lake City, UT. , , 2013.
  • Brixner DI. Personalize Health Care November 26, 2012 Meeting. [Presentation] Panel Discussion: Outcomes and Cost Effectiveness in Personalized Health Care. University of Utah, Salt Lake City, UT. November 26, 2012. , , 2012.
  • Does Formulary Management Have To Change To Accommodate Personalized Medicine? FMCP 2nd Annual Research Symposium: Contemporary Applications for Specialty Pharmacy Research. Cincinnati, Ohio. , , 2012.
  • A Pilot Study of Screening Outcomes in Patients at Risk for Atherosclorosis in the Utah Community Clinics. 5th Annual Utah Health Services Research Conference. Salt lake City, UT. , , 2009.
  • Hamilton M, Biskupiak J, Brixner DI, Xianying P, Xianchen L, Ghate S. Oral Anticoagulant Discontinuation in Patients with Nonvalvular Atrial Fibrillation and Cardiac Surgery. Poster session presented at American Heart Association Scientific Sessions 2013, Dallas, TX. Poster, Presented, 2013.
  • Brixner DI, Mavros P, Goodman, M, Unni S, Ye X.. Prevalence Of Hypertension And Extent Of Blood Pressure Control In Patients With Chronic Kidney Disease: Evidence From Ambulatory Care Data In The US. Poster session presented at American Heart Association Scientific Sessions 2013, Dallas, TX. Poster, Presented, 2013.
  • Jiao T, Liou TG, Young D, Brixner DI. A Comparison of Demographic and Clinical Variables of Down Syndrome Patients in Utah and the United States. Poster session presented at ISPOR 16th Annual European Congress, Dublin, Ireland. Poster, Presented, 2013.
  • Rochau U, Sroczynski G, Wolf D, Schmidt S, Jahn B, Conrads-Frank A, Stenehjem D, Brixner DI, Radich J, Gastl G, Siebert U. Uncertainty and Cost-effectiveness Analysis of the Sequential Application of Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia. Poster session presented at ISPOR 16th annual European Congress, Dublin, Ireland. Poster, Presented, 2013.
  • Stenehjem D, Jiao T, Rhien T, Bellows BK, Kaldate RR, Jones J, Brixner DI. Literature Review and Assessment to Populate a Decision-analytic Model Evaluating a Novel Prognostic in Early Lung Cancer. Poster session presented at ISPOR 16th Annual European Congress, Dublin, Ireland. Poster, Presented, 2013.
  • Schall I, Saverno K, Luzak A, Mitrovic M, Gothe H, Brixner D, Siebert U. The Impact of Generic Substitution on Health Outcomes and Costs: A Systematic Review. Poster session presented at The Convention Centre, Dublin, Ireland. Poster, Presented, 2013.
  • Rochau U, Kluibenschaedl M, Stenehjem D, Kuo KL, Jahn B, Brixner DI, Siebert U. U.S. Physican Survey to Populate a Decision-analytic Model For the Treatment of Chronic Myeloid Leukemia. Poster session presented at ISPOR 16th Annual European Congress, Dublin, Ireland. Poster, Presented, 2013.
  • Udomaksorn S,Stenehjem D,Welch B,Cheng Y,Anderson L,Colonna S,Neumayer L, Brixner DI. Evaluation of Variable Relevance and Accessibility to Support Personalized Medicine in Breast Cancer. Poster session presented at ISPOR 16th Annual European Congress, Dublin, Ireland. Poster, Presented, 2013.
  • Schall I, Saverno K, Luzak A, Mitrovic M, Gothe H ,Brixner DI, Siebert U. Impact of Generic Substitution on Health Outcomes and Costs: A Systematic Review. Poster session presented at ISPOR 16th Annual European Congress, Dublin, Ireland. Poster, Presented, 2013.
  • Stenehjem D, Yoo, M, Unni S, Singhal M, Bauer H, Savarno K, Quaah C, Masaquel A, Brixner DI. Assessment of Single-institution HER2 Testing Patterns, Rate of HER2+ Disease and Utilization of Trastuzumab in Early Breast Cancer. Poster session presented at ASCO’s Quality Care Symposium, San Diego, CA. Poster, Presented, 2013.
  • Rochau U, Sroczynski G, Wolf D, Schmidt S, Jahn B, Conrads-Frank A, Stenehjem D, Brixner DI, Radich J, Gastl G, Siebert U. Cost-Effectiveness Analysis of the Sequential Application of Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia. Poster session presented at Society of Medical Decision Making 35th Annual Meeting, Baltimore, MD. Poster, Presented, 2013.
  • McAdam-Marx C, Bellows B, Wygant G, Mukherhee J, Unni S, Ye X, Liberman JN, Iloeji U, Brixner DI. Association of >5% Weight Loss and Self-Reported Adherence with 6-Month Glycemic Control in Type 2 Diabetes Mellitus (T2DM): the DELTA Study. Poster session presented at American Diabetes Association’s 73th Scientific Sessions, Chicago, IL. Poster, Presented, 2013.
  • McAdam-Marx C, Bellows B, Wygant G, Mukherjee J, Unni S, YeX, Iloeji U, Brixner DI. Associations Between Claims Based Adherence, Weight Loss and Glycemic Control in Patients with Type 2 Diabetes. Poster session presented at ISPOR (International Society For Pharmacoeconomics and Outcomes Research), New Orleans, Louisiana. Poster, Presented, 2013.
  • Welch B, Udomaksorn S, Cheng Y, Stenehjem D, Colonna S, Kawamoto K, Brixner DI. Desired Attributes for a Point-of-Care Breast Cancer Clinical Dashboard Supporting Personalized Health Care. Poster session presented at 2013 Cleveland Clinic Personalized Healthcare Summit, Cleveland, Ohio. Poster, Presented, 2013.
  • Chen S, Lee Y, Alas V, Angalakuditi M, Brixner DI. Prevalence of Undiagnosed Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus. Poster session presented at National Kidney Foundation Spring Meeting, Orlando, FL. Poster, Presented, 2013.
  • Rochau U, Sroczynski G, Wolf D, Schmidt S, Conrads-Frank A, Jahn B, Saverno K, Brixner DI, Gastl G, Radich J, Siebert U. Choosing a Tyrosine Kinase Inhibitor as First-line Therapy for Chronic Myeloid Leukemia under The Uncertainty of Long-term Effectiveness and SafetyEvidence Based Medicine. Poster session presented at Evidence Based Medicine Conference, Berlin, Germany. Poster, Presented, 2013.
  • Jiao, T, Goodman, M, Brixner, DI. Are Utah and United States Down Syndrome Patients Different? University of Arizona. Poster session presented at Western Pharmacoeconomics Conference, Tucson, Arizona. Poster, Presented, 2013.
  • Cai B, Saokaew S, Stenehjem D, Kuo K, Bauer H, Albright F, Brixner DI. Treatment Pattern and Outcomes of Ovarian Cancer Patients in a Patient-Centered Retrospective Research Registry. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • Hamilton, M, Liu, X, Brixner DI, Biskupiak J. Utilization Patterns of Anticoagulants in Non-Valvular Atrial Fibrillation after the entry of Novel Oral Anticoagulants in the United States. Poster session presented at American Heart Association, Los Angeles, CA. Poster, Presented, 2012.
  • Rochau U, Sroczynski G, Wolf D, Schmidt S, Conrads-Frank A, Jahn B, Saverno K, Brixner DI, Gastl G, Radich J, Siebert U. Targeted Therapy with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Decision-Analytic Model. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • Rochau U, Sroczynski G, Wolfe D, Schmidt S, Conrads-Frank A, Jahn B, Saverno K, Brixner D, Gastl G, Radich J, Siebert U. Decision-analytic Model for the First-line Therapy of Chronic Myeloid Leukemia. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • Saokaew S, Cai B, Kuo K, Bauer H, Albright F, Brixner DI, Stenehjem D. Treatment Patterns and Outcomes of Breast Cancer Patients in a Patient-centered Retrospective Research Registry. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • Brixner DI. Application of Real World Data to Inform a Breast Cancer Decision-analytic Model in Austria and the U.S. – Preliminary Outcomes of Data Collection. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • McAdam-Marx C, Bellows B, Wygant G, Mukherjee J, Unni S, Ye X, Brixner DI, lloeje U. Weight Loss of ≥3% of Body Weight After Initiating New Anti-diabetic Therapy is Associated With Glycemic Control at 6 Months in Patients With Type 2 Diabetes. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • Brixner DI. Decision-analytic Model for the First-line Therapy of Chronic Myeloid Leukemia. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • Rochau U, Kallinger S, Schmidt S, Saverno K, Holzner B, Schwarzer R, Arvandi M, Brixner DI, Gastl G, Siebert U. Quality of Life Assessment of Chronic Myeloid Leukemia Patients in Austria: Cross-sectional Pilot Study Using the EQ-5D. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • McAdam-Marx C,, Bellows B, Wygant G, Mukherjee J, Unni S, Ye X, Liberman JN, Lloeje U, Brixner DI. Association of ≥3% Weight Loss and Self-Reported Adherence With 6-Month Glycemic Control in T2DM: the DELTA* Study. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • Kuo K, Saokaew S. Cai B, Bauer H, Albright F, Brixner DI, Stenehjem D. Treatment Patterns and Outcomes of Melanoma Patients in a Patient Centered Retrospective Research Registry. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • Saokaew S, Cai B, Kuo K, Bauer H, Albright F, Brixner DI, Stenehjem D. Treatment Patterns and Outcomes of Breast Cancer Patients in a Patient-centered Retrospective Research Registry. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • Beate J, Stenehjem D, Saverno K, Cai B, Siebert W, Brixner DI. Preliminary Outcomes Towards a Risk-Based Microsimulation Decision-Analytical Model Based on Treatment and Cost Inputs From a Real World Cohort of Breast Cancer Patients. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • Brixner DI, Lising A, Gothe H, Haussler B, Dragovich C. Supporting Payers with Collaborative HTA Tools in Making Evidence-based Decisions: The U.S. Experience and International Needs in Europe and Globally. Poster session presented at ISPOR 15th Annual European Congress, Berlin, Germany. Poster, Presented, 2012.
  • Jahn B, Stenehjem D, Saverno K, Cai B, Siebert U, Brixner DI. Preliminary Outcomes Towards a Risk-Based Microsimulation Decision-Analytical Model Based on Treatment Cost Inputs From a Real World Cohort of Breast Cancer Patients. Poster session presented at The 34th Annual Meeting of the Society for Medical Decision Making, Phoenix, AZ. Poster, Presented, 2012.
  • Beate J, Stenehjem D, Saverno K, Cai B, Siebert W, Brixner DI. Preliminary Outcomes Towards a Risk-Based Microsimulation Decision-Analytical Model Based on Treatment and Cost Inputs From a Real World Cohort of Breast Cancer Patients. Poster session presented at The 34th Annual Meeting of the Society for Medical Decision Making, Phoenix AZ. Poster, Presented, 2012.
  • Stenehjem D, Albright F, Guo A, Chen L, Raimundo K, Bauer H, Brixner DI. Assessing Real-world Response Monitoring and Tolerability of Imatinib Treatment in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and A Chart Review Analysis of Monitoring and Patterns of Treatment Switching in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) on Imatinib. Poster session presented at 14th International Conference CML- Biology and Therapy, Baltimore, MD. Poster, Presented, 2012.
  • Stenehjem D, Kuo K, Bauer H, Barney R, Albright F, Brixner DI. Outcomes and treatment patterns of hepatocellular carcinoma patients stratified by staging-guided treatment categories in a patient-centered retrospective research registry. [Poster]. Poster session presented at ISPOR 5th Asia-Pacific Conference, Taipei, Taiwan. Poster, Presented, 2012.
  • Marcus RL, Ghate S, Brixner DI, LaStayo P. Relative Sarcopenia and Not Absolute Sarcopenia Impacts Physical Performance in Non-Obese Older Adults. [Poster]. Poster session presented at The Gerontological Society of America, Albuquerque, NM. Poster, Presented, 2012.
  • Saverno K, Rochau U, Schmidt S, Stenehjem D, Kallinger S, Gastl G, Brixner DI, Siebert U. Comparison of Chronic Myeloid Leukemia Registries in Austria and Utah, USA. [Poster]. Poster session presented at 9th Annual Meeting of Health Technology Assessment International, Bilbao, Spain. Poster, Presented, 2012.
  • Oderda G, Holtorf AP, Brixner DI. Health Economic and Outcomes Research (HEOR) Evidence in Health Technology Assessment (HTA) for Drug Formulary and Reimbursement Decisions across Global Regions. [Poster]. Poster session presented at HTAi Annual Meeting, Bilboa, Spain. Poster, Presented, 2012.
  • Schwarzer R, Rochau U, Saverno K, Jahn B, Bornschein B, Lackner M, Sroczynski G, Schall I, Schnell-Inderst P, Flatscher-Thöni M, Gothe H, Pugner K, Brixner DI, Siebert U. Do existing cost-effectiveness thresholds adequately support decision making for PCM? A review of international practice. [Poster]. Poster session presented at 14th Biennial European Meeting of the Society for Medical Decision Making (SMDE Europe 2012), Oslo, Norway. Poster, Presented, 2012.
  • Jahn B, Brixner DI, Saverno K, Rochau U, Stenehjem D, Albright F, Siebert U. Application of Real World Data to Inform A Decision -Analytic Model in Breast Cancer in Austria and the U.S. [Poster]. Poster session presented at 14th Biennial European Meeting of the Society for Medical Decision Making, Oslo, Norway. Poster, Presented, 2012.
  • Stenehjem D, Albright F, Saverno K, Rochau U, Siebert U, Brixner DI. Real World Data Inform a Decision Analytic Model in Breast Cancer in Austria and the U.S. Poster session presented at Biennial European Meeting of the Society for Medical Decision Making (SMDM Europe 2012), Oslo, Norway. Poster, Presented, 2012.
  • Stenehjem D, Albright D, Gou A, Chen L, Raimundo K, Bauer H, Brixner, DI. Real-world response monitoring and tolerability of imatinib treated chronic myeloid leukemia patients captured in a retrospective research registry. [Poster]. Poster session presented at ASCO Meeting, Chicago, IL. Poster, Presented, 2012.
  • Stenehjem D, Albright D, Gou A, Chen L, Raimundo K, Bauer H, Brixner, DI. Real-world response monitoring and tolerability of imatinib treated chronic myeloid leukemia patients captured in a retrospective research registry. [Poster]. Poster session presented at ASCO Meeting, Chicago, IL. Poster, Presented, 2012.
  • Stenehjem D, F. Albright F, K. Kuo K, K. Raimundo K, Brixner DI. Evaluating Contemporary Practice in CML via a Retrospective Research Registry of Patients across a Comprehensive Cancer Center Database. Poster session presented at International Society For Pharmacoeconomics and Outcomes Research, 17th Annual International Meeting, Washington, DC. Poster, Presented, 2012.
  • Dhamane AD, Martin B, Brixner DI, Hudson TJ, Said Q. Assessment of Metabolic Monitoring of Patients Prescribed Second Generation Antipsychotics (SGAS) Using Electronic Medical Record (EMR) Data. Poster session presented at ISPOR 15th Annual International Meeting, Atlanta, GA. Poster, Presented, 2012.
  • Bellows B, McAdam-Marx C, Unni S, Ye X, Mukherjee J, Brixner DI. 12-month HbA1c and Weight Outcomes by Drug Class in Treatment Naïve Patients with Type 2 Diabetes. [Poster]. Poster session presented at AMCP Meeting, San Francisco, CA. Poster, Presented, 2012.
  • Dye J, Bellows B, Holtorf A, Brixner, DI. Use of Pharmacoeconomic and Outcomes Research in Formulary Decision Making: A Tale of Two Surveys. Poster session presented at AMCP Meeting, San Francisco, CA. Poster, Presented, 2012.
  • Dye J, Bellows B, Holtorf A, Brixner DI. Use of Pharmacoeconomic and Outcomes Research in Formulary Decision Making: A Tale of Two Surveys. Poster session presented at AMCP Meeting, San Francisco, CA. Poster, Presented, 2012.
  • McAdam-Marx C, Brixner D, Ye X, Unni S, Mukherjee J. Weight Loss, Independent of Drug Class, Predicts HBA1C Goal Attainment in Patients 65 Years and Older in a Real-World Setting. [Poster]. Poster session presented at ISPOR 14th Annual European Congress, Madrid, Spain. Poster, Presented, 2011.
  • Bron M, Bellows B, Ye X, Yu J, Rapala S, Oderda G, Brixner DI. Prevalence and Cost of Cardiovascular Events Predicted by Body Mass Index Risk Factors: a Decision Tree Analysis. Poster session presented at Obesity 2011 - the 29th Annual Scientific Meeting of The Obesity Society, Orlando, FL. Poster, Presented, 2011.
  • McAdam-Marx C, Brixner D, Ye X, Unni S, Mukherjee J. Weight loss of 3% or more in a 12-month period is associated with glycaemic control in newly treated type 2 diabetes patients in the usual care setting. [Poster]. Poster session presented at 47th EASD Annual Meeting, Lisbon, Portugal. Poster, Presented, 2011.
  • Brixner DI. Comparison of the Trends in Prevalence of Overweight among Adolescents on Antipsychotics to Non-Users from 2000 to 2009. Poster session presented at 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL. Poster, Presented, 2011.
  • Bron M, Bellows B, Ye X, Yu J, Rapala S, Oderda G, Brixner DI. Prevalence-Adjusted Cost of Comorbities in Overweight/Obese Patients with a Body Mass Index. [Poster]. Poster session presented at American Diabetes Association 71st Scientific Sessions, San Diego, CA. Poster, Presented, 2011.
  • Brixner DI, Bron M, Bellows B, Ye X, Harikrishnan V, Oderda G. Prevalence-Adjusted Cost of Comorbidities in Overweight/Obese Patients With a Body Mass Index 25-34.9 vs ≥35. [Poster]. Poster session presented at ISPOR 16th Annual International Meeting, Baltimore, MD. Poster, Presented, 2011.
  • Kwong J, Cho S, Ghate S, Brixner DI, Fox E. Adverse Outcomes Following Substitution of Warfarin Products in Atrial Fibrillation Patients. Poster session presented at 45th ASHP Midyear Clinical Meeting & Exposition, Anaheim, CA. Poster, Presented, 2010.
  • Brixner, DI. Evaluation of Support Services to Colorectal Cancer Patients in Mexico. Poster session presented at ISPOR 13th Annual European Congress, Prague, Czech Republic. Poster, Presented, 2010.
  • Brixner DI. Current and Future Use of Pharmacoeconomic and Outcomes Research Data in Decision Making in the USA. Poster session presented at ISPOR 13th Annual European Congress, Prague, Czech Republic. Poster, Presented, 2010.
  • Tasic D, Brixner DI, Goodman MJ. The Impact of Oral Antidiabetics on Weight in the Elderly with Type 2 Diabetes Mellitis in the Ambulatory Setting. Poster session presented at ISPOR 15th Annual International Meeting International Society of Pharmacoeconomics and Outcomes Research, Atlanta, GA. Poster, Presented, 2010.
  • McAdam-Marx C, Brixner DI. Approach To Matching Alzheimer's Disease Patient and Their Spouses to Assess Caregiver Burden in an Administrative Claims Database. Poster session presented at ISPOR 15th Annual International Meeting, Atlanta, GA. Poster, Presented, 2010.
  • Brixner DI. Comparing Adherence Measures Against One-Year Outcomes for Patients with Epilepsy. Poster session presented at AMCP 22nd Annual Meeting and Showcase, San Diego, CA. Poster, Presented, 2010.
  • Zinman B, Falahati A, Conner C, Brixner D. Meta-analysis estimate of number needed to treat to achieve a composite outcome (A1C ≤7%, no weight gain and no hypoglycemia) for liraglutide, a human GLP-1 analog, across six randomized controlled trials. Poster session presented at 44th ASHP Midyear Clinical Meeting & Exhibition, December 6–10, 2009, Las Vegas, Nevada. Poster, Presented, 2009.
  • McAdam-Marx C, Yu J, Shankar V, Bounchard J, Aagren M, Brixner DI. Average Daily Dose of Analog basal Insulins in Patients with Type 2 Diabetes: A Matched Case Control Analysis. Poster session presented at IDF World Diabetes Congress, Montreal, Canada. Poster, Presented, 2009.
  • Brixner DI, McAdam-Marx C, Nelson R, Aagren M, Bouchard J. Analysis of Glycemic control and Weight Changes in Patients Treated with Analog Basal Insulin in a Real-World Setting. Poster session presented at IDF 20th World Diabetes Congress, Montreal, Canada. Poster, Presented, 2009.
  • Said Q, Rosenblatt LC, Ghate S, Whitehead R, Brixner DI. Real World Impact of Second-generation Antipsychotics on Weight Gain in Adolescents [Poster]. Poster session presented at Institute on Psychiatric Services, New Orleans, LA. Poster, Presented, 2007.
  • Kane S, Magowan S, Accortt N, Brixner DI. Predictors of 5-ASA Prescription Persistence During the Chronic Phase in Patients with Ulcerative Colitis [Poster]. Poster session presented at American College of Gastroenterology 2007 Annual Scientific Meeting, Philadelphia, PA. Poster, Presented, 2007.
  • LaFleur J, McAdam-Marx C, Asche CV, Alder S, Sheng X, Brixner DI, Silverman S. Clinical Risk Factors for Fractures are Additive Postmenopausal Woman Who Are at Risk for Fracture in a Primary Care Setting [Poster]. Poster session presented at 29th Annual Meeting of the American Society for Bone and Mineral Research. Honolulu, HI. Poster, Presented, 2007.
  • Biskupiak J, Brixner DI, Munger M, Keskinaslan A. Effectiveness of Amlodipine Valsartan Combination Therapy in Primary Care [Poster] European Society of Hypertension. Poster session presented at 17th European Meeting on Hypertension. Milan, Italy. Poster, Presented, 2007.
  • Jackson K, Brixner DI, Oderda G, Oberg B, Sheng X, Keskinaslan A. Compliance and Economic Outcomes with Valsartan and HCTZ Combination Therapy for Hypertensive Patients [Poster]. Poster session presented at American Society of Hypertension. Poster, Presented, 2007.
  • Kane S, Magowan S, Accortt N, Brixner DI. Predictors of 5-ASA Prescription Persistence in Patients with Ulcerative Colitis [Poster]. Poster session presented at Digestive Disease Week 2007, Washington, D.C. Poster, Presented, 2007.
  • Brixner DI, Magowan S, Accortt N. Prescription Refill Behavior for Nifedipine Therapy is Significantly Dependent on Medication Cost [Poster]. Poster session presented at 8th American Heart Association Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington D.C. Poster, Presented, 2007.
  • Said Q, Gutterman E, Kim M, L'Italien G, Chen C, Whitehead R, Brixner DI. The Association Between Antipsychotic Treatment and Unintentional Injury in Patients Diagnosed with Psychiatric Disorder [Poster]. Poster session presented at American Psychiatric Association 160th Annual Meeting, San Diego, CA. Poster, Presented, 2007.
  • Said Q, Ghates S, Rosenblatt L, Whitehead R, Brixner DI. Real World Impact of Second-generation Antipsychotics on Weight Gain in an Adolescent Population [Poster]. Poster session presented at American Psychiatric Association 160th Annual Meeting, San Diego, CA. Poster, Presented, 2007.
  • Brixner DI. Assessment of Physician Prescribing for Primary Care Patients with Chronic Obstructive Pulmonary Disease (COPD) in a National Electronic Medical Research (EMR) Database. [Poster]. Poster session presented at American College of Clinical Pharmacy 2007 Spring Practice and Research Forum, Memphis, TN. Poster, Presented, 2007.
  • LaFleur J, McAdam-Marx C, Asche CV, Alder S, Sheng X, Brixner DI, Silverman S. The Risk of clinical Vertebral Fracture for Postmenopausal Patients with Specific Combinations of Fracture Risk Factors in a Primary-Care Setting [Poster]. Poster session presented at 7th International Symposium on Osteoporosis: Translating Research into Clinical Practice, Washington, D.C. Poster, Presented, 2007.
  • Brixner DI, Magowan S, Accortt N. Evaluation of Prescription Refill Patterns Based on Daily Dosing Regimen and Pil Load for Calcium Channel Blockers. [Poster]. Poster session presented at Academy of Managed Care Pharmacy 19th Annual Meeting and Showcase, San Diego, CA. Poster, Presented, 2007.
  • Brixner DI, Said Q, Oderda G, Kirkness C. Assessment of the clinical Risk Factors for Cardiometabolic Risk in a National Primary Care Electronic Medical Record (EMR) Database. [Poster]. Poster session presented at Academy of Managed Care Pharmacy 19th Annual Meeting and Showcase, San Diego, CA. Poster, Presented, 2007.
  • Brixner DI, McAdam-Marx C, Gallwitz W, Roper M, Asche CV. Value of Reducing Vertebral Fractures in Women with Post-Menopausal Osteoporosis with Multiple Clinical Risk Factors for Fracture Based on the TOP Study [Poster]. Poster session presented at American Society of Health-System Pharmacists 41st Midyear Clinical Meeting, Anaheim, CA. Poster, Presented, 2006.
  • Haak S, Nickman N, Rusho W, Beck S, LaFleur J, Brixner D. Joint Professional Analysis of a Novel Dosage form in the Intensive Care (ICU) Setting. Poster session presented at American Association of Critical Care Nurses, Anaheim, CA. Poster, Presented, 2006.
  • Haak S, Nickman N, Rusho W, Beck S, LaFleur J, Brixner DI. Joint Professional Analysis of a Novel Proton Pump Inhibitor (PPI) Dosage Form [Poster]. Poster session presented at American Association of Critical-Care Nurses, National Teaching Institute and Critical-Care Exposition, Anaheim, CA. Poster, Presented, 2006.
  • Brixner DI, Nickman N, Oderda GM. Documentation of pharmacy cost in the preparation of chemotherapy infusions in academic and community based oncology practices. Poster session presented at International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Asian Congress, Shanghai. Poster, Presented, 2006.
  • Said Q, Ho MJ, Beckwith MC, Brixner DI. A Pharmacoeconomic Comparison of Oral Fluorquinolones for Complicated Urinary Tract Infections. Poster session presented at Academy of Managed Care Educational Conference, Nashville, TN. Poster, Presented, 2005.
  • Brixner, DI. Documentation of pharmacy cost in the preparation of chemotherapy infusions in academic and community based oncology practices. Poster session presented at International Society of Pharmacoeconomics and Outcomes Research (ISPOR), 8th European Congress, Florence, Italy. Poster, Presented, 2005.
  • Joish VN, Brixner DI, LaFleur J, Kirkness C. Pharmacoeconomic Analysis of ARB Therapy in Patients with Mild-to-Moderate Hypertension. Poster session presented at Academy of Managed Care Pharmacy 2005 Educational Conference. Poster, Presented, 2005.
  • Joish VN, Brandy E, Stockdale WA, Dirani R, Brixner DI. Identification and Diagnosis of COPD in a Primary Care Setting. Poster session presented at International Conference American Thoracic Society Meeting, San Diego, CA. Poster, Presented, 2005.
  • Brixner DI, Said Q, Newcomer J, Tuomari V, Oderda GM, Stockdale W, L'Italian GJ. Diagnostic Coding for Patients on Second Generation Anti-psychotics in Real World. Poster session presented at American Psychiatric Association 158th Annual Meeting, Atlanta, GA. Poster, Presented, 2005.
  • Brixner DI, Ho MJ, Sauer BC, Stockdale WA. Real world usage of weight gain drugs in patients on second-generation antipsychotics. Poster session presented at American Diabetes Association, San Diego, CA. Poster, Presented, 2005.
  • Joish VN, Stockdale WA, Brady E, Dirani R, Brixner DI. An assessment of diagnosis and treatment of COPD in primary care via an electronic medical record database. Poster session presented at International Society of Pharmacoeconomics and Outcomes Research, Washington, D.C. Poster, Presented, 2005.
  • Brixner DI, Ho MJ, Sauer BC, Stockdale WA. Development of an integrated diabetes database across community clinics and hospitals. Poster session presented at International Society of Pharmacoeconomics and Outcomes Research 10th Annual International Meeting, Washington, D.C. Poster, Presented, 2005.
  • LaFleur J, Thompson CJ, Joish VN, Charland S, Oderda GM, Brixner DI. Adherence and Persistence with Lipid-Lowering Pharmacotherapy: Effects of the Covariates Copay and Disease Severity on Probabilities of Being Categorized as Compliant. Poster session presented at American College of Clinical Pharmacy 2005 Spring Practice and Research Forum and Updates in Therapeutics, Myrtle Beach, South Carolina. Poster, Presented, 2005.
  • Brixner DI, Borisov NN, Burge RT, Steinbuch M. Cost Analysis of Osteoporosis Treatments: A Managed Care Perspective. Poster session presented at National Osteoporosis Foundation, Sixth International Symposium on Osteoporosis, Washington, DC. Poster, Presented, 2005.
  • LaFleur J, Fowler MA, McBeth C, Oderda L, Gunning K, Steinvoort C, Stockdale W, Oderda GM. Prevalence of drug-related problems among Medicaid high utilizers as identified by clinically-trained pharmacist reviewers. Poster session presented at American College of Clinical Pharmacy 2005 Spring Practice and Research Forum and Updates in Therapeutics, Myrtle Beach, SC. Poster, Presented, 2005.
  • LaFleur J, Beckwith C, Fowler M, Tyler L, Brixner DI. A Pharmacoeconomic Comparison of Oral Third-Generation Cephalosporins for Acute Otitis Media. Poster session presented at American Society of Health-System Pharmacy 39th Midyear Clinical Meeting, Orlando, FL. Poster, Presented, 2004.
  • Brixner DI, Asche C, Chang J, Stewart J, Paladino JA. Economic value of telithromycin vs. clarithromycin in the treatment of community-acquired pneumonia. Poster session presented at 39th American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL. Poster, Presented, 2004.
  • LaFleur J, Thompson C, Ho MJ, Stockdale WA, Charland S, Oderda GM, Brixner DI. Adherence, persistence, and cost of lipid-lowering pharmacotherapy: ER-niacin/statin combination therapy within a single dosage-form versus two separate dosage forms in a managed care population. Poster session presented at Academy of Managed Care Pharmacy 2004 Educational Conference, Baltimore, MD. Poster, Presented, 2004.
  • Ho MJ, LaFleur J, Brixner D. What is the cost for Atypical Antipsychotics for Schizophrenia: Efficacy versus Effective Doses. Poster session presented at Academy of Managed Care Pharmacy 2004 Educational Conference, Baltimore, MD. Poster, Presented, 2004.
  • Ho MJ, LaFleur J, Brixner DI. Which atypical antipsychotics for schizophrenia: cost-efficacy versus cost-effectiveness analyses. Poster session presented at Academy of Managed Care Pharmacy Educational Conference, Baltimore, MD. Poster, Presented, 2004.
  • Stockdale WA, Brixner DI. Comorbidity influence index. Poster session presented at International Society of Pharmacoeconomics and Outcomes Research 9th Annual Meeting, Arlington, VA. Poster, Presented, 2004.
  • Joish VN, Donaldson G, Stockdale WA, Oderda GM, Brixner DI, Sasane R, Joshua-Gotlib S, Crawely JA. Economic burden of GERD and PUD in an employed population. Poster session presented at International Society of Pharmacoeconomics and Outcomes Research 9th Annual Meeting, Arlington, VA. Poster, Presented, 2004.
  • Ho MJ, Joish VN, LaFleur J, Christensen RL, Brixner DI. Which oral triptan for migraine: a cost-efficacy analysis from a managed care perspective. Poster session presented at Academy of Managed Care 16th Annual Meeting and Showcase, San Francisco, CA. Poster, Presented, 2004.
  • Christensen RL, LaFleur J, Ho MJ, Joish VN, Brixner DI. Which HMG-CoAreductase inhibitor for hyperlipiemia: a cost-effectiveness analysis based on the STELLAR trial. Poster session presented at Academy of Manage Care 16th Annual Meeting and Showcase, San Francisco, CA. Poster, Presented, 2004.
  • Oderda GM, Gunning KM, LaFleur J, Stockdale WA, Tyler LS, Parke D, Brixner DI. Reviews of Utah Medicaid high utilizers to control drug costs. Poster session presented at International Society of Pharmacoeconomics and Outcomes Research Spring Meeting, Arlington, VA. Poster, Presented, 2003.
  • Gunning KM, Oderda GM, Stockdale WA, LaFleur J, Orlando PL, Steinvort C, Dang K, Tyler LS, Brixner DI. Controlling Utah Medicaid drug spending through a regiment review program. Poster session presented at American College of Clinical Pharmacy, Orlando, FL. Poster, Presented, 2003.
  • Oderda LH, Stockdale WA, Oderda GM, Donaldson G, Ashburn M, Brixner DI, Lipman AG. Age and Gender-Stratified Differences in Quality of Life in Elderly Chronic Pain Patients. Poster session presented at ISPOR Spring Meeting, Arlington, VA. Poster, Presented, 2003.
  • Brixner DI, Shoheiber O, Polino C, Lin C. Analysis of Compliance Across Four Therapeutic Drug Classes in a Pharmacy Claims Database. Poster session presented at Academy of Managed Care Pharmacy 9th Annual Meeting, New Orleans, LA. Poster, Presented, 1997.
  • Brixner DI, Sasane R, Goodwin W. Step Analysis of Patients Iniated on ACEI or CCB Therapy in a Managed Care Setting. Poster session presented at Academy of Manage Care Pharmacy 9th Annual Meeting, New Orleans, LA. Poster, Presented, 1997.
  • Demarinis RM, Arthur D. Little Health Economic Group, Brixner DI. Economic Analysis of Nabumetone, Ibuprofen, and Combination Ibuprofen and Misoprotol in the Treatment of Elderly Patients with Osteorarthritis. Poster session presented at Hawaii Society of Hospital Pharmacists Annual Meeting. Poster, Presented, 1992.

Languages

  • English, Fluent.
  • German, Fluent.

Publications

  • Stanford J, Martin J, Gibson M, Birdsall E, Brixner DI (date unknown). Use of Clomiphene Citrate in the University of Utah Community Clinics. Accepted, .
  • Trost LF 3rd, Wender RC, Suter CC, Rosenberg JH, Brixner DI, Von Worley AM, Gunter MJ, National Epilepsy Management Panel. (date unknown). Management of epilepsy in adults. Diagnosis guidelines. Vol. 118, 22-6. Accepted, .
  • Saverno K, Neu, G, Schmidt S, Wolf D, Conrads-Frank A, Jahn B, Sroczynski G, Brixner, DI (date unknown). Medical Decision Analysis for the First-line Therapy of Chronic Myeloid Leukemia. Accepted, .
  • Dhamane AD, Martin BC, Brixner DI, Hudson TJ, Said Q (date unknown). Metabolic monitoring of patients prescribed second-generation antipsychotics. Vol. 19, 360-74. Accepted, .
  • Hawkes JE, Mittal M, Davis M, Brixner D (date unknown). Impact of Online Prescription Management Systems on Biologic Treatment Initiation. Vol. 36, 2021-2033. Accepted, .
  • Vermeulen LC, Windisch PA, Rydman RJ, Bruskiewitz RH, Brixner DI, Vlasses PH (date unknown). Using a multihospital systems framework to evaluate and establish drug use policy. Vol. 24, 235-46. Accepted, .
  • Frost N, Freeman J, Brixner D, Mort J, Clem J, Ngorsuraches S (date unknown). Patients' preferences and willingness-to-pay for disease-modifying therapies. Vol. 35, 55-60. Accepted, .
  • Brixner D, Rubin DT, Mease P, Mittal M, Liu H, Davis M, Ganguli A, Fendrick AM (date unknown). Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. Vol. 25, 770-779. Accepted, .
  • Ghate SR, Porucznik CA, Said Q, Hashibe M, Joy E, Brixner DI (date unknown). Association Between Second-generation Antipsychotics and Changes in Body Mass Index in Adolescents. Vol. 52, 336-43. Accepted, .
  • Brixner DI, Oderda GM, Nickman NA, Beveridge R, Jorgenson JA (date unknown). Documentation of chemotherapy infusion preparation costs in academic- and community-based oncology practices. Vol. 4, 197-208. Accepted, .
  • Brixner DI, Oderda GM, Nickman NA, Servatius D, Lambert A, Bancroft F, Bretzel R, Beveridge R, Vermulen L, Lentz S (date unknown). Documentation of pharmacy cost in the preparation of chemotherapy infusions in academic and community-based oncology practices. Accepted, .
  • Kuehl M, Brixner DI, Broom AD, Avery TL, Blakley RL (date unknown). Cytotoxicity uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice. Vol. 48, 1481-8. Accepted, .
  • Schwarzer R, Rochau U, Saverno K, Jahn B, Bornschein B, Muehlberger N, Flatscher-Thoeni M, Schnell-Inderst P, Sroczynski G, Lackner M, Schall I, Hebborn A, Pugner K, Fehervari A, Brixner DI, Siebert U. (date unknown). Systematic overview of cost-effectiveness thresholds in ten countries across four continents with a special focus on personalized cancer medicine. Accepted, .